Payden & Rygel’s Medtronic PLC Position
Does Payden & Rygel own Medtronic PLC (MDT)? Not currently — the last reported position was 120.9K shares worth $11M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$11M
Q2 2023
Shares
120.9K
% of Portfolio
+0.75%
Quarters Held
18
position exited
Position History MDT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 120.9K | $11M | +0.75% |
| Q1 2023 | 107.5K | $9M | +0.51% |
| Q4 2022 | 1.5K | $117,000 | +0.01% |
| Q3 2022 | 1.5K | $121,000 | +0.01% |
| Q2 2022 | 46.9K | $4M | +0.25% |
| Q1 2022 | 323.3K | $36M | +1.81% |
| Q4 2021 | 128.2K | $13M | +0.61% |
| Q3 2021 | 7.7K | $965,000 | +0.05% |
| Q2 2021 | 7.7K | $956,000 | +0.05% |
| Q1 2021 | 232.4K | $27M | +1.28% |
| Q4 2020 | 226.1K | $26M | +1.36% |
| Q3 2020 | 222.1K | $23M | +1.37% |
| Q2 2020 | 352.9K | $32M | +2.06% |
| Q1 2020 | 364.3K | $33M | +2.37% |
| Q4 2019 | 334.3K | $38M | +2.37% |
| Q3 2019 | 301.9K | $33M | +2.23% |
| Q2 2019 | 220.3K | $21M | +1.47% |
| Q1 2019 | 212.9K | $19M | +1.42% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Payden & Rygel’s full portfolio or all institutional holders of MDT.